key: cord-0759206-055ln69w
authors: Ogedegbe, Gbenga; Inouye, Sharon K.
title: Injustice in Health: Now Is the Time to Change the Story
date: 2021-03-30
journal: Ann Intern Med
DOI: 10.7326/m21-1279
sha: bc6a9f2f76d812e7413a4d526971be71a92eef44
doc_id: 759206
cord_uid: 055ln69w

Daily news headlines highlight the disproportionate effect of COVID-19 on minoritized communities, particularly those that are socioeconomically disadvantaged. Thus, the findings that Bilal and colleagues report are unsurprising. Yet, they provide a level of granularity that reveals a public health catastrophe in the making.

D aily news headlines highlight the disproportionate effect of COVID-19 on minoritized (Black, Latinx, Asian, and Indigenous) communities, particularly those that are socioeconomically disadvantaged. (A "minoritized" group is often defined as a social group that is devalued in society and given less access to resources because of their race, ethnicity, or other attributes that are beyond their control.) Thus, the findings that Bilal and colleagues report (1) are unsurprising. Yet, they provide a level of granularity and clarity that reveals a stark story of a public health catastrophe in the making.

Bilal and colleagues analyzed the correlation between the Social Vulnerability Index (SVI) for 281 ZIP codes in Chicago, Philadelphia, and New York City and department of health data on numbers of COVID-19 tests done, confirmed COVID-19 cases, and COVID-19 deaths. The SVI is a robust measure of social vulnerability and a marker of a community's ability to prevent human suffering and financial loss in the event of a disaster. It includes 15 variables from the American Community Survey, comprising 4 domains: socioeconomic status, household composition, race and language barriers, and housing and transportation. The authors found a striking relationship between higher SVI (more vulnerable) and lower testing rates, higher positivity rates, more confirmed cases, and greater COVID-19-related mortality. In fact, mortality increased by 50% for each SD increase in SVI. Of note, clusters of high SVI and high COVID-19 mortality occurred in well-recognized areas of extreme racial segregation and poverty, including West and North Philadelphia, the West Side of Chicago, and the Bronx.

Important limitations of this study should be acknowledged. First, ZIP codes can contain heterogeneous populations. Thus, the SVI may not reflect all individuals in a ZIP code, which may have contributed to paradoxical findings in some ZIP codes. Second, the SVI is a gross indicator that cannot directly illuminate the mechanisms of increased infection and mortality. Poor outcomes were likely due to complex interactions of higher comorbidity burden, decreased access to health care, lower-quality hospitals, barriers to testing, and other factors. Finally, as the authors note, lack of testing in these areas made confirmation of cases difficult, and they may have underestimated COVID-19 cases and deaths.

Despite these limitations, the findings have important implications. Although other studies have shown the disparate rates of COVID-19 mortality and hospitalization in minoritized populations (2), few offer insights into the role of structural inequities. Adhikari and colleagues (3) also showed in 10 major U.S. cities that ZIP codes with predominantly Black and Latinx populations had 3-fold higher rates of COVID-19-related hospitalizations and death regardless of socioeconomic status. Of note, the National Center for Health Statistics reported a loss of 3 years in life expectancy for Black men, versus 0.8 year for White men, in the first half of 2020 (4); this was largely attributed to the disparate effect of COVID-19 in minoritized populations. Bilal and colleagues confirm the role that residing in a socioeconomically disadvantaged community plays in this disparate effect.

Unfortunately, this story continues with regard to COVID-19 vaccination. Recent, age-adjusted data across 40 states show that Black and Latinx persons received a lower share of vaccinations than White persons relative to their share of cases and deaths and to their proportion of the population (5). As of 10 March 2021, about 1 250 370 residents of New York City had received at least 1 dose of the COVID-19 vaccine, reaching 19% of the White population but only 9% of the Black and Latinx populations who make up more than 50% of New York City's residents (6). If underlying structural inequities remain unaddressed, the persistent racial and ethnic disparities in rates of vaccination and health care delivery will continue to perpetuate the higher rates of COVID-19-related morbidity and mortality in minority communities.

What is the way forward? The advent of COVID-19 vaccines has sharply reduced overall hospitalizations and mortality and could play a major role in reducing the racial gap in morbidity and mortality related to COVID-19. Recent discourse on low vaccination rates in minority populations has focused on "vaccine hesitancy" rather than on the structural inequities-reflected in high SVI scores-that likely drive poor access to vaccines. A recent analysis documented much lower access to vaccines for minoritized populations than White populations (7) . A strong and immediate policy response is imperative to address these issues. Bilal and colleagues' study sheds light on the important role that structural inequities play in disparities in COVID-19 outcomes and also provides policymakers evidence that they must ensure and prioritize vaccine distribution to areas with high SVI. Equitable vaccine distribution targeted to low-income areas is critical to alter the current trajectory of poor vaccination access and poor COVID-19 outcomes in minoritized communities. Although the ethics and legality have been questioned (8) , the National Academies of Sciences, Engineering, and Medicine recommend prioritizing vaccination of racial minorities (9) . An alternative approach for vaccine distribution that does not include race might apply the area deprivation index, a measure of socioeconomic deprivation of a geographic area (block level) that is associated with health outcomes (10) . Through deliberate application of such an approach, we can reduce racial disparities in vaccine access.

Perhaps a silver lining of the COVID-19 pandemic is the renewed and sustained focus on the role that structural inequities play in racial disparities across not only health care but also the criminal justice, education, housing, and financial systems. This recognition has led to important initial steps to address the root causes of racial disparities in health care: establishment of the Biden-Harris COVID-19 Health Equity Taskforce to address structural inequity in health care; the Biden-Harris administration's pledge to make all adults eligible for vaccination against COVID-19 by 1 May 2021; and the recent Coronavirus Aid, Relief, and Economic Security Act to

Spatial inequities in COVID-19 testing, positivity, confirmed cases, and mortality in 3 U.S. cities. An ecological study

Variation in COVID-19 hospitalizations and deaths across New York City boroughs

Assessment of community-level disparities in coronavirus disease 2019 (COVID-19) infections and deaths in large US metropolitan areas

Provisional life expectancy estimates for

Latest data on COVID-19 vaccinations race/ethnicity. Kaiser Family Foundation

Black people need better vaccine access, not better vaccine attitudes

Is it lawful and ethical to prioritize racial minorities for COVID-19 vaccines

A framework for equitable allocation of vaccine for the novel coronavirus. National Academies of Sciences, Engineering, and Medicine; 2020. Accessed at www .nationalacademies.org/our-work/a-framework-for-equitable-allocation -of-vaccine-for-the-novel-coronavirus on 16

Making neighborhood-disadvantage metrics accessible -the Neighborhood Atlas

Current Author Addresses: Dr. Ogedegbe: